ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 004225908. A total of 4 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,052 | +57.5% | 50,500 | +81.0% | 0.00% | 0.0% |
| Q2 2023 | $668 | +26.0% | 27,900 | -1.1% | 0.00% | – |
| Q1 2023 | $530 | -20.7% | 28,200 | -32.9% | 0.00% | -100.0% |
| Q4 2022 | $668 | -99.9% | 42,000 | -26.8% | 0.00% | 0.0% |
| Q3 2022 | $939,000 | -46.4% | 57,400 | -53.8% | 0.00% | -50.0% |
| Q2 2022 | $1,751,000 | -51.0% | 124,300 | -15.7% | 0.00% | -33.3% |
| Q1 2022 | $3,572,000 | -53.1% | 147,500 | -54.8% | 0.00% | -62.5% |
| Q4 2021 | $7,611,000 | +551.1% | 326,100 | +590.9% | 0.01% | +700.0% |
| Q3 2021 | $1,169,000 | +1.4% | 47,200 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,153,000 | -46.8% | 47,300 | +5531.0% | 0.00% | -75.0% |
| Q1 2021 | $2,167,000 | – | 840 | +205.5% | 0.00% | – |
| Q4 2020 | $0 | – | 275 | +12.2% | 0.00% | – |
| Q3 2020 | $0 | – | 245 | +102.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 121 | -53.5% | 0.00% | -100.0% |
| Q1 2020 | $1,098,000 | -66.0% | 260 | -65.6% | 0.00% | -71.4% |
| Q4 2019 | $3,234,000 | +56.6% | 756 | +31.7% | 0.01% | +16.7% |
| Q3 2019 | $2,065,000 | +159.4% | 574 | +92.6% | 0.01% | +200.0% |
| Q2 2019 | $796,000 | -1.1% | 298 | -0.7% | 0.00% | 0.0% |
| Q1 2019 | $805,000 | -52.3% | 300 | -71.3% | 0.00% | -60.0% |
| Q4 2018 | $1,688,000 | +33.5% | 1,044 | +71.4% | 0.01% | +25.0% |
| Q3 2018 | $1,264,000 | +234.4% | 609 | +145.6% | 0.00% | +300.0% |
| Q2 2018 | $378,000 | +613.2% | 248 | -40.2% | 0.00% | -50.0% |
| Q1 2018 | $53,000 | +10.4% | 415 | +59.6% | 0.00% | 0.0% |
| Q4 2017 | $48,000 | -65.5% | 260 | -19.8% | 0.00% | -66.7% |
| Q3 2017 | $139,000 | +768.8% | 324 | +55.8% | 0.01% | +500.0% |
| Q2 2017 | $16,000 | -88.4% | 208 | -77.0% | 0.00% | -83.3% |
| Q1 2017 | $138,000 | -2.1% | 905 | -20.5% | 0.01% | -25.0% |
| Q4 2016 | $141,000 | +107.4% | 1,139 | +98.1% | 0.01% | +60.0% |
| Q3 2016 | $68,000 | -24.4% | 575 | +4.2% | 0.01% | -16.7% |
| Q2 2016 | $90,000 | -80.0% | 552 | -58.7% | 0.01% | -83.3% |
| Q1 2016 | $450,000 | +56.2% | 1,337 | +266.3% | 0.04% | +56.5% |
| Q4 2015 | $288,000 | -7.7% | 365 | +25.9% | 0.02% | 0.0% |
| Q3 2015 | $312,000 | +6.8% | 290 | +54.3% | 0.02% | -4.2% |
| Q2 2015 | $292,000 | -24.4% | 188 | -66.6% | 0.02% | -46.7% |
| Q1 2015 | $386,000 | – | 563 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $2,818,000 | 0.16% |
| SIMPLEX TRADING, LLC | 124,300 | $1,751,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 67,800 | $955,000 | 0.00% |
| JANE STREET GROUP, LLC | 102,600 | $1,446,000 | 0.00% |
| JPMORGAN CHASE & CO | 102,700 | $1,447,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |